Source: google_news
Source ID: google_news:658f833c80ec86c72bb93fe99d38c21c:RGNX
URL: https://news.google.com/rss/articles/CBMikwFBVV95cUxOOWVNTmJkYkQ3S2U2Q3VPRGFGdGptM0pSM09lVklydXU0Z1Nmano2ejdrQnhCQ09vWW43bXRzUFFCVEhLaENrM2YxRm1kOEctMkZPSFgyWEhRVGVnWGktWGtOZFVwc3RWZEZMYk9CWVljOVFnMjRlaGx1WTIteHV6NEU5TzVQZEQ0amt4TkVrcnZtRGs?oc=5
Symbol: (RGNX)
Published: 2026-10-16 03:00:00 EDT
Time precision: minute
Title: RGX-202 Meets Primary End Point in Phase 3 Duchenne Trial - NeurologyLive

RGX-202 Meets Primary End Point in Phase 3 Duchenne Trial
NeurologyLive